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Abstract
Background: With the availability of new generation sequencing technologies, bacterial genome projects have undergone
a major boost. Still, chromosome completion needs a costly and time-consuming gap closure, especially when containing
highly repetitive elements. However, incomplete genome data may be sufficiently informative to derive the pursued
information. For emerging pathogens, i.e. newly identified pathogens, lack of release of genome data during gap closure
stage is clearly medically counterproductive.
Methods/Principal Findings: We thus investigated the feasibility of a dirty genome approach, i.e. the release of unfinished
genome sequences to develop serological diagnostic tools. We showed that almost the whole genome sequence of the
emerging pathogen Parachlamydia acanthamoebae was retrieved even with relatively short reads from Genome Sequencer
20 and Solexa. The bacterial proteome was analyzed to select immunogenic proteins, which were then expressed and used
to elaborate the first steps of an ELISA.
Conclusions/Significance: This work constitutes the proof of principle for a dirty genome approach, i.e. the use of
unfinished genome sequences of pathogenic bacteria, coupled with proteomics to rapidly identify new immunogenic
proteins useful to develop in the future specific diagnostic tests such as ELISA, immunohistochemistry and direct antigen
detection. Although applied here to an emerging pathogen, this combined dirty genome sequencing/proteomic approach
may be used for any pathogen for which better diagnostics are needed. These genome sequences may also be very useful
to develop DNA based diagnostic tests. All these diagnostic tools will allow further evaluations of the pathogenic potential
of this obligate intracellular bacterium.
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Introduction
The recent availability of new generation sequencing technol-
ogies [1,2] has provided unprecedented sequencing capacity,
enabling the acquisition of genome-scale sequences at an
extraordinary fast rate. These innovative techniques provide
amazing opportunities for high-throughput structural and func-
tional genomic researches and have been applied to date to a
variety of contexts such as whole-genome sequencing [3] and
resequencing [4], targeted resequencing [5], non coding RNA [6]
or DNA-binding of modified histones [7,8]. These high-through-
put sequencing methods avoid the need for in vivo cloning and
achieve a high accuracy. Even homopolymer problems, i.e. the
major drawback of 454 pyrosequencing, may be overcome by
reaching high sequence coverage [1]. These new technologies
greatly reduce the work, time and expenses of such projects.
However, the relative short read length makes genome assembly
problematic and their use in bacterial genomics has been fairly
restricted to new strains closely related to already sequenced
organisms to identify for example virulence factors [9], antibiotic
resistance genes [10], or epidemiological markers [11]. Although
improved techniques can now achieve paired-read information
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and longer reads [12], genomes still need a costly and time-
consuming gap closure step, especially when containing highly
repetitive elements such as transposases and recombination hot
spots.
Still, complete genomic information is not necessarily needed
and incomplete genome data obtained using high-throughput
sequencing methods may potentially be informative enough to
derive the pursued information. Moreover, the low time to results
of such approaches (about 15 weeks [9]) is especially useful when
genomic information are readily needed for instance in case of
outbreaks (i) to search for the presence of specific pathogenicity
island or virulence genes, (ii) to identify specific or multicopy gene
targets in order to rapidly develop a reliable molecular diagnosis
test, and (iii) to identify immunogenic proteins to set up a
diagnostic tool for sero-epidemiological investigations or to
develop a vaccine.
This strategy is particularly interesting for obligate intracellular
bacteria such as members of the Chlamydiales order that lack a
genetic manipulation system and only replicate within eukaryotic
cells of different origins including humans, animals and amoebae
[13]. One of them, Parachlamydia acanthamoebae strain Hall’s coccus,
was initially isolated from the water of an humidifier at the origin
of a fever outbreak [14], and since then some evidences have
accumulated suggesting the role of this species as an emerging
human respiratory pathogen [15]. An emerging pathogen refers
here to an agent that has been recently identified as pathogenic.
Indeed, several serological and molecular studies supported a role
of P. acanthamoebae in patients with community-acquired and
aspiration pneumonia [16,17,18]. P. acanthamoebae also appeared to
possibly cause bronchiolitis in children [19]. Moreover, pneumo-
nia has been reproduced in a murine model following intranasal
and intratracheal inoculation with P. acanthamoebae [20,21]. Finally,
the ability of Parachlamydia to resist to human macrophages [22,23]
further supported its human pathogenicity. Besides, the role of P.
acanthamoebae in bovine abortion has been clearly demonstrated
since the bacteria was detected by PCR, immunohistochemistry
and electron microscopy in the placenta of aborted bovines [24].
The pathogenic potential of Parachlamydia towards humans and
animals still remains largely unexplored since this strict intracel-
lular bacterium does not grow on media routinely used for the
detection of pathogens. To date, there are only few strains of
Parachlamydia acanthamoebae available worldwide. Moreover, little
information is available about strains from cattle and other
animals, since no Parachlamydia strains have been isolated from
animal samples by cell culture. It is thus important to develop new
diagnostic approaches for P. acanthamoebae to better understand its
epidemiological and pathogenic potentials in various human and
animal diseases.
In this work, we undertook a proof of principle project that
investigated the feasibility of combining genomic and proteomic
approaches to rapidly identify immunogenic proteins. We showed
that, even with relatively short reads from Genome Sequencer 20
(GS20) and after homopolymer correction through Solexa, we can
gather almost the whole genome sequence of an emerging
pathogen, allowing to analyze the proteome and to elaborate the
first steps of an ELISA test, thus enabling to further evaluate its
pathogenic role.
Results
Genome Sequencing
The pyrosequencing of P. acanthamoebae genomic DNA by two
runs of GS20 yielded 566’453 reads of an average length of
111 nucleotides. In order to correct eventual frameshifts due to
homopolymer errors, genomic DNA was also sequenced with
Solexa technology, which produced 1’655’941 short reads of
36 bp that could be assembled in 8616 contigs. The latters were
assembled with GS20 reads in 95 contigs larger than 500 bp, with
a N50 size of 101’998 bp. The coverage obtained with 454 reads
was of 17x whereas that obtained with Solexa reads was of 12x.
The 95 contigs represents approximately 97% of the total genome
and as many as 99.99% of all the non-repeated regions, i.e. when
excluding contigs exhibiting a sequence depth higher than 30x
with 454. As indicated by the total length of the contigs, the
complete genome of P. acanthamoebae Hall’s coccus stands around
3 Mb and was predicted to contain 4798 open reading frames
larger than 90 nucleotides. More than 91% of the large contigs
were covered with Solexa. The 1037 differences between Solexa
and 454 were manually inspected. As many as 405 differences
could be attributed to the presence of homopolymers and were
corrected according to Solexa whereas the remaining 632
differences were mainly due to inaccurate Solexa contig ends
and were not corrected.
Identification of Immunoreactive Proteins
To identify immunoreactive proteins that could be used in a
diagnostic test, total proteins of P. acanthamoebae elementary bodies
were separated by 2D gel electrophoresis and either Coomassie
blue-stained or transferred onto nitrocellulose membranes.
Immunoblots were performed with sera of rabbits immunized
with P. acanthamoebae and with human P. acanthamoebae positive sera
(Fig. 1A,C). Spots corresponding to immunogenic proteins
reacting with at least one rabbit anti-Parachlamydia serum were
selected by computer-assisted matching of the Coomassie blue-
stained gel and immunoblots, and further analyzed by mass
spectrometry. Eighteen different proteins were identified (Fig. 2A),
out of which 5 reacted only against sera from immunized rabbits
and 13 reacted with both rabbit and human Parachlamydia positive
sera. Some of these proteins, such as chaperonin GroEL (Hsp60),
DnaK (Hsp70), elongation factor Tu and the ribosomal proteins
S1 and L7/L12, were already known to be antigenic [25] (Fig. 2B
and Table S1). Some classical Chlamydiales immunogenic proteins,
such as 60 kDa cysteine-rich OMP, LcrE or CPAF protease
[25,26,27] were not detected. Since the corresponding genes were
found in our contig assembly, these proteins are likely poorly
expressed in elementary bodies or when the bacteria are co-
cultivated in amoebae. Membranes were also probed with control
human sera, i.e. either completely negative for any member of the
Chlamydiales order (Fig. 1B), or positive only for C. psittaci (Fig. 1D)
or C. pneumoniae (see Table S2). Based on 2D immunoblots with
control sera and blast analysis of the MS identified proteins, the
best candidates for a diagnostic assay of P. acanthamoebae infection
were determined (see Table S2). Antigens displaying a high
sequence homology with similar proteins in other species as well as
proteins cross-reacting with non specific or negative sera were
discarded. The two best candidate proteins were selected for
evaluation in an ELISA test (Fig. 2B).
Western-Blot and ELISA of Proteins E and N
The parachlamydial protein E and N, which have no sequence
homology with any known protein, were chosen to develop
serological diagnostic tools. Recombinant proteins E (MW
,58 kDA) and N (MW ,30 kDA) were expressed in E. coli and
purified thanks to a 6His tail fused to their N-terminal end. The
purified recombinant proteins were detected by western blot with
a rabbit anti-Parachlamydia serum or with a human P. acanthamoebae
positive serum (Fig. 3A,C). Lower molecular weight bands
also visible on these blots probably correspond to degradation
The Dirty Genome Approach
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products. Moreover, faint bands were detectable when protein E
was probed with a C. psittaci positive serum indicating a low level of
cross reaction with this organism. For both proteins, no signal was
obtained when Chlamydiales negative or C. pneumoniae positive sera
were tested.
When used as antigen in a direct ELISA assay, purified proteins
E and N were detected by the sera of two rabbits immunized with
P. acanthamoebae until a dilution value of 1/256 while only
background reaction is observed with pre-immune sera at this
and lower dilutions (Fig. 3B,D). For both proteins, a significant
difference was observed in the level of reactivity of the two sera.
However, both rabbit sera exhibited good antigen reactivity when
tested by western-blot. Overall, these data demonstrate the
potential of immunogenic proteins E and N for serological
diagnostic tests that could be developed in the future.
Comparison between Combined or Separated 454 and
Solexa Approaches to Identify Proteins
In addition to identifying immunogenic proteins, the most
abundantly expressed proteins of P. acanthamoebae elementary
bodies were also analyzed. A total of 95 Coomassie blue-stained
spots were analyzed by mass spectrometry and a reliable protein
identification was obtained for 85 of them using the combined
GS20 and Solexa sequences. Identification failed for 2 proteins
due to the absence of signal by mass spectrometry and for 8
proteins due to the absence of hits in the genome-derived protein
database. In many cases multiple spots on the gel corresponded to
a single protein so that 61 different proteins were identified,
including the immunoreactive proteins described above (see
Fig. S1).
All 61 proteins identified using combined GS20 and Solexa
sequences would also have been identified when using only the
GS20 sequences-derived protein database. However, with uncor-
rected GS20 sequences, 4 ORFs presented a frameshift leading
twice to a longer protein and twice to a premature end of the
protein, i.e. splitting the ORF in two parts. Only 5 of the 61
proteins identified using combined GS20 and Solexa sequences
were identical to the predicted ORFs using only Solexa sequences.
The remaining 56 proteins were split between two to seven
different small contigs preventing their accurate identification by
Mascot. The limited performance of Solexa technology as
compared to 454 is likely due to the short Solexa reads and the
relative low sequence depth obtained.
Most Abundantly Expressed Proteins and Virulence
Genes
By BLAST against nr database, a function could be derived for
half of the 61 proteins identified by mass spectrometry (for details,
see Table S1 and Table S3), whereas one fourth have homologs
of unknown function in Protochlamydia amoebophila genome [33] or
in other organisms. Finally, the remaining proteins exhibit no
significant homology with any known amino acid sequence.
Figure 1. 2D patterns of the immunoreactive proteins of P. acanthamoebae. Proteins of P. acanthamoebae separated by 2D gel
electrophoresis were probed with (A) serum from immunized rabbit #1, (B) a Chlamydiales negative human serum, (C) a P. acanthamoebae positive
human serum, and, (D) a C. psittaci positive human serum. Five immunogenic proteins are numbered in reference to the following figures.
doi:10.1371/journal.pone.0008423.g001
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Figure 2. 2D map and identification of P. acanthamoebae immunogenic proteins. A. Proteins reacting with at least one rabbit anti-
Parachlamydia serum were excised from gel and analysed by MALDI TOF mass spectrometry. Spots successfully identified are numbered. Molecular
mass standards are indicated on the right side of the gel. B. The potential of 18 immunogenic proteins for use in a serological diagnostic test was
evaluated based on their reactivity with control sera and on their sequence similarity in BLASTP results (see Table S2 for detailed analysis).
doi:10.1371/journal.pone.0008423.g002
The Dirty Genome Approach
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Our assembly also enabled the identification of several virulence
genes present in P. acanthamoebae genome. In addition to the
previously mentioned LcrE and CPAF protease, P. acanthamoebae
encodes a complete type three secretion system (T3SS), including
components of the secretory apparatus, translocators, T3SS
specific chaperones and effectors [28]. Like in other Chlamydiales
Figure 3. Western blot and ELISA with recombinant proteins E and N. Purified recombinant protein E (A) and N (C) were blotted on a
nitrocellulose membrane and probed with a rabbit anti-Parachlamydia serum (rabbit #1), a rabbit pre-immune serum (rabbit #1), a P.
acanthamoebae positive human serum, a Chlamydiales negative human serum, a C. psittaci positive human serum and a C. pneumoniae positive
human serum. Proteins E (B) and N (D) were used as antigen in a direct ELISA. Sera from 2 rabbits immunized with P. acanthamoebae and pre-
immune (pi) sera were tested in duplicates.
doi:10.1371/journal.pone.0008423.g003
The Dirty Genome Approach
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species, T3SS genes are spread in distinct conserved genomic
clusters (see Fig. S2). Interestingly, sctJ and sctC, two genes
encoding components of the secretory apparatus, are duplicated in
the genome. Moreover, four clear homologs to Protochlamydia
amoebophila nucleotide transporters (ntt_1, ntt_2, ntt_3 and ntt_4)
which play a key feature in energy parasitism [29,30] have been
identified in P. acanthamoebae. A fifth putative ADP/ATP translo-
case candidate was also detected but homologies were not
sufficient to establish the substrate transport specificity. Finally,
four genes belonging to the F-like conjugative DNA transfer
operon located on the genomic island of Protochlamydia amoebophila
[31] were also detected in P. acanthamoebae (traU, traN, traF and
pc1435).
Discussion
In case of outbreak due to a new pathogen, diagnostic tests must
be developed rapidly. Genome sequence is an important resource
to develop various tools for molecular and serological diagnostic,
specific monoclonal antibodies production or vaccine design. With
the availability of high throughput sequencing strategies such as
the widely used GS20/GSFLX [1], large sequence datasets are
now obtained within very short time. However, the costly and
time-consuming follow up necessary to close the gaps delays the
release and accessibility of most genome sequences. As shown for
Francisella tularensis, a rapid comparative genome analysis can be
successfully applied on unfinished contigs enabling to uncover
genomic rearrangements or gene mutations that could be involved
in an increased strain virulence and resistance [9]. A similar
approach was also proposed to study the role of Helicobacter pylori in
chronic gastric infection by analyzing genetic changes in this
species over time or between infected humans [32].
A rapid and public availability of raw genome data from an
emerging pathogen at the origin of an outbreak is critical to permit
the development of various diagnostic tools by medical microbi-
ologists. The delay before genome release is especially crucial in
case of new pathogenic agents with the absence of available closely
related genomes, i.e. absence of scaffold that may be used to
facilitate assembly and gap closure steps. This problem was faced
here for P. acanthamoebae with the availability of a single published
genome within the Parachlamydiacaeae family, that of Protochlamydia
amoebophila [33]. The presence of repeated elements in the genome
significantly increases the number of contigs obtained, thus
prolonging the gap closure. Although Chlamydiaceae genomes do
not contain many transposases, the genome sequence of
Protochlamydia amoebophila was much more invaded by such
repeated components [33]. This suggests that sequence repetitions
probably account for a large number of gaps in our own
Parachlamydia genome project. Nevertheless, if these repeated
elements can prevent an assembly in one unique contig, they do
not hinder the availability of most coding sequences. Indeed, 90%
of analyzed proteins could be identified, the remaining 10% being
uncharacterized due either to the lack of mass spectrometry signal
or to the lack of hits in the ORF database. Thus, although we
could not determine the exact number of immunogenic proteins
that have been missed due to the presence of the remaining gaps,
we may estimate that only few (,10%) additional immunogenic
proteins would have been identified if a complete genome
sequence was available.
Our proteomic approach allowed us to detect 18 immunogenic
proteins among which are several antigens already described as
highly immunoreactive such as GroEL, DnaK or elongation factor
Tu [25]. Five proteins represented good/possible candidates to
develop a diagnostic test since exhibiting significant reactivity to
sera taken from humans infected by Parachlamydia as well as from
immunized rabbits and no cross-reactivity to sera from humans
infected with C. pneumoniae, C. psittaci and negative controls. Then,
we focused on only two of these five proteins, E and N, displaying no
significant homology with any known amino acid sequence. Their
potential to develop vaccine or diagnostic tools was suggested by
western-blot and by preliminary ELISA tests despite the absence, in
the heterologous protein expression system used, of post-transla-
tional modifications such as glycosylation or phosphorylation that
might have resulted in poor serum recognition. Given its 96-well
format, the ELISA test, once developed, would be very useful in
large epidemiological studies to assess the precise seroprevalence of
Parachlamydia antibodies in human population and to confirm the
pathogenic role of this intracellular bacterium in human lower
respiratory tract infections and in bovine abortion. Moreover, an
ELISA based on a given immunogenic protein will be more specific
than diagnostic microimmunofluorescence and western-blot assays
based on whole bacterial proteins.
Interestingly, among the 85 ORFs identified using our dirty
genome sequences, only 9 proteins could have been identified by
Mascot versus protein sequences of the closest related bacteria
available to date, Protochlamydia amoebophila, all of which are very
conserved and, if immunogenic, would likely produce strong cross
reactions when used in serological tests. In addition, among the five
immunogenic proteins selected as good and possible candidates for
the development of a diagnostic ELISA, none have been identified
by Mascot versus SPTrembl database because of the differences
between the peptides identified and the protein database. Moreover,
the two proteins we considered as the best candidates have no
homologs in other genomes and their sequences could not be
derived from those of any related or unrelated bacteria.
This further emphasizes the need for a protein database directly
derived from genome sequences of the studied emerging pathogen.
Besides, rapid genome sequencing provides information useful not
only for proteomics but also for comparative genomics, transcrip-
tomics, cell biology and molecular biology. The availability of most
genome sequences of a new emerging pathogen isolated during an
outbreak may also be important to design molecular diagnostic
tools, to define epidemiological marker as well as to identify
virulence genetic traits and antibiotic resistance determinants.
The advantages of using mass spectrometry associated with an
unfinished genome to identify immunogenic proteins, compared to
other approaches such as phage display library [34,35], compar-
ative genomic [36] or systematic expression of all ORFs [37],
resides mainly in the minimal necessary workload and in the
rapidity of the method. Indeed, the whole process can take place in
less than 4 months, with only 2 weeks necessary to obtain the
contigs (Fig. 4). In addition, with the lowering of sequencing costs,
the price of such an approach is highly competitive. Furthermore,
constructing random expression libraries by fractionation of whole
bacterial DNA would likely identify less immunogenic proteins
since any plasmid carrying ORFs whose product is toxic will not
be successfully expressed.
The 4 months that it takes to develop an ELISA may seem long
as compared to the few weeks needed to develop a DNA-based
test. However, detecting proteins represents a distinct advantage
over detecting unique DNA sequences, and the availability of a
serological test may especially prove very useful (i) to confirm
positive PCR results (that may be false positive due to PCR
contamination) and to better document a given case, (ii) to perform
large seroepidemiological studies in order to precise the mode of
transmission of a new pathogen and (iii) to investigate the possible
role of a new bacterial pathogen in different clinical settings, such
as pericarditis and endocarditis, for which valvular/pericardial
The Dirty Genome Approach
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fluid samples are not easily available. Similarly, when investigating
patients with atypical pneumonia, serum samples are easier to
obtain than lower respiratory tract specimen, especially when
patients present a non-productive cough. Moreover, for several
fastidious intracellular bacteria, even highly sensitive PCR tests
may fail in detecting the agent at the infection site (i) due to
relatively low bacterial load, e.g. sensitivity of only 50% to detect
Borrelia in cerebrospinal fluid taken from patient with neurological
Lyme disease [38], (ii) due to the presence of inhibiting molecules
present in clinical samples, or (iii) due to ‘‘sampling bias’’ of PCRs
tests performed on tissue samples, e.g. sensitivity of 60% of PCR
on valve samples taken from patients with definite endocarditis
[39].
Furthermore, the identification of immunogenic proteins also
allows the development of species specific immunohistochemistry,
that is useful (i) to confirm the presence of the pathogen in the
tissue lesions, (ii) to analyze retrospectively various biopsy samples
taken from patients with infection of unknown etiology and (iii) to
shed some light on the underlying pathogenesis in vivo, by
precising which cells are infected using double staining.
In summary, this work constitutes the proof of principle for a
dirty genome approach, i.e. the use of unfinished genome
sequences of pathogenic bacteria, coupled with proteomics to
rapidly identify immunogenic proteins useful to develop a specific
diagnostic test. Indeed, genomic information concerning new
emerging pathogens must be placed at the scientific community’s
disposal as soon as possible, since their retention in order to close
all gaps before genome publication is clearly medically counter-
productive. This work demonstrated that 454/Solexa combined
dirty genomes are sufficient and useful for medical downstream
applications.
Methods
Ethics Statement
Human sera used in this work (see below) have been obtained
from patients and control subjects, as part of prospective studies.
These clinical studies have been accepted by the local ethical
committee of the University of Lausanne. Both patients and
controls gave their informed consent for various serological
investigations including study of their serum reactivity against
Parachlamydia acanthamoebae.
Cultivation and Purification of P. acanthamoebae
Parachlamydia acanthamoebae strain Hall’s coccus was grown in
Acanthamoeba castellanii strain ATCC 30010 in peptone yeast-extract
glucose broth (PYG) and purified using a sucrose barrier and a
gastrographin gradient, as previously described [22].
Chromosome Sequencing and Assembly
Purified P. acanthamoebae elementary bodies resuspended in PBS
were lysed for DNA extraction with QIAamp DNA mini kit
(Qiagen) according to the manufacturer protocol. Genomic DNA
was pyrosequenced by two runs of Genome Sequencer 20 [1].
Genomic DNA was also sequenced using Solexa technology in
Illumina Genome Analyzer [2]. Solexa sequences were assembled
using Edena software [40] with parameter m=16. Both GS20
runs only or GS20 runs and Solexa contigs were compiled in one
assembly using Newbler software V1.1.02 with default parameters
except for overlap size (45 nt) and identity score (95%). Differences
between 454 and solexa contigs were manually inspected and
corrected when necessary. In case of homopolymer discrepancy
preference was generally given to Solexa when correcting
frameshifts in protein coding region and in potentially non coding
regions.
Gene Prediction and Annotation
To improve the prediction of incomplete genes at contig ends, a
stop encoding tag ‘‘CTAGCTAGCTAG’’ was added at both
extremities of each contig. A reference proteome was created with
all open reading frames (stop to stopORF) for peptide identification.
Besides, locally installed Glimmer v3.02 [41] trained on long ORFs
of the concatenated contigs was then applied to predict gene
position on contigs longer than 500 bp. All reported ORFs larger
than 100 nt were submitted to BLASTP versus nr database and
local InterProScan search. Finally, tRNAscan-SE [42] and
RNAmmer [43] were used to find structural RNAs. Genes of
special importance for this study were manually annotated. This
Whole Genome Shotgun project has been deposited at DDBJ/
EMBL/GenBank under the accession ACZE00000000. The
version described in this paper is the first version, ACZE01000000.
Crude Extract Sample Preparation and 2D Gel
Electrophoresis
Bacterial cells resuspended in PBS were washed in 10 mM Tris,
5 mM MgAc, pH 8.0 and then lysed by 5 cycles of short-pulse
sonication in lysis buffer (30 mM Tris, 7 M urea, 2 M Thiourea,
Figure 4. Time scale of a dirty genome approach combined
with proteomics to develop serological diagnostic tools.
Schematic representation of the main steps of genome sequencing,
immunogenic proteins identification and testing of candidate proteins
in an ELISA. In bold, approximate time necessary to complete each step.
doi:10.1371/journal.pone.0008423.g004
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4% CHAPS, pH 8.5). Proteins were recovered by centrifugation
at 6’000 g and their concentration determined using a Bradford
assay (Quick StartTM Bradford Protein Assay, Biorad, Hercules,
USA).
Two dimensional gel electrophoresis was performed as
described by Centeno et al. [44] using approximately 150 mg
(mini gels) or 600 mg (midi-gels) of total elementary bodies
proteins. Proteins were visualized by Coomassie Blue staining or
transferred to nitrocellulose for subsequent immunoblot analysis
(see Methods S1).
Human Sera
P. acanthamoebae positive human sera were described in previous
studies where their positivity was assessed by immunofluorescence
and western-blot [17,45]. Control sera were taken from women
with at term uneventful pregnancy [45]. Chlamydiales negative sera
were tested negative by immunofluorescence for reactivity against
various members of the Chlamydiales order (P. acanthamoebae, W.
chondrophila, S. negevensis, N. hartmannellae, C. trachomatis, C. pneumoniae
and C. psittaci), C. pneumoniae positive sera were positive for C.
pneumoniae but negative for all other Chlamydiales tested. C. psittaci
positive human serum was taken from a patient who suffered from
well-documented psittacosis [46].
ELISA
Proteins E and N cloned and expressed in E. coli were purified
thanks to a 6His tail (see Methods S1). Then, 96-well ELISA
microplates were coated with 100 ng of purified E or N proteins in
carbonate buffer pH 9.6 and incubated overnight at 4uC. After
blocking with 3% non-fat dry-milk in PBST (PBS + 0.1% Tween
20) during 1 hour at 37uC, plates were washed with PBST and
incubated 2 hours at 37uC with serial two-fold dilutions, in
PBST+1% non-fat dry-milk, of sera from 2 rabbits immunized
with P. acanthamoebae and of corresponding pre-immune sera. After
3 subsequent washes with PBST, plates were incubated 1 hour at
37uC with horseradish peroxidase-conjugated anti-rabbit IgG (Cell
Signaling, Allschwill, Switzerland) diluted 1:1000 in PBS + 1%
non-fat dry-milk. Plates were washed 5 more times with PBST. O-
phenylenediamine dihydrochloride (OPD) in citrate buffer was
used as substrate for the peroxydase. After 15 minutes incubation,
the optical density was read at 492 nm using an ELISA reader
(Multiskan Ascent, Thermo Scientific, Waltham, USA).
Additional Methods
Descriptions of sera from immunized rabbits, immunoblot
analysis, mass spectrometry and cloning, expression and purifi-
cation of immunogenic proteins E and N are available in
Methods S1.
Supporting Information
Methods S1 Supplementary Methods
Found at: doi:10.1371/journal.pone.0008423.s001 (0.03 MB
DOC)
Table S1 Identification of P. acanthamoebae immunogenic pro-
teins. Putative protein description of each immunogenic protein
identified by mass spectrometry, according to BLASTP results
against nr database or Chlamydiales genomes, respectively. Note
that one protein spot, as for exemple F or P, can match with
similar MS scores with two different ORFs, resulting in two
different protein descriptions. Moreover, different spots such as D,
T and U, can match with different ORFs which have the same
protein description and thus correspond to orthologous or
paralogous proteins.
Found at: doi:10.1371/journal.pone.0008423.s002 (0.03 MB
XLS)
Table S2 Western blot recognition of identified immunogenic
proteins with human sera. Immunogenic proteins identified by
mass spectrometry (see Table S1) were tested by western blotting
of 2D gels with two sera positive for P. acanthamoebae, two sera
positive for C. pneumoniae, one serum positive for C. psittaci and two
sera negative for most Chlamydiales. Results are evaluated in the
perspective of a Parachlamydia specific serological diagnostic test.
Found at: doi:10.1371/journal.pone.0008423.s003 (0.03 MB
XLS)
Table S3 Identification of P. acanthamoebae most abundantly
expressed proteins. Putative protein description of each open
reading frame identified by mass spectrometry (see Figure S1),
according to BLASTP results against nr database or Chlamydiales
genomes, respectively. Note that one protein spot, as for exemple
20 and 29, can match with similar MS scores with two different
ORFs, resulting in two different protein descriptions. Moreover,
different spots such as 35 and 36, can match with different ORFs
which have the same protein description and thus correspond to
orthologous or paralogous proteins.
Found at: doi:10.1371/journal.pone.0008423.s004 (0.05 MB
XLS)
Figure S1 2D map of most abundantly expressed P. acanthamoe-
bae proteins. Proteins of P. acanthamoebae elementary bodies were
separated by 2D gel electrophoresis and stained with Coomassie
blue. Spots successfully identified by mass spectrometry are
numbered A–S for immunogenic proteins and 1–29 for non
immunogenic proteins (See Table S1 and Table S3).
Found at: doi:10.1371/journal.pone.0008423.s005 (5.01 MB TIF)
Figure S2 Genetic organization of identified T3SS genes. The
conserved genes are represented by different colors according to
their respective functions. Hypothetical proteins are represented in
light gray and genes encoding for proteins with identified functions
likely not involved in T3SS are represented in dark gray. Capital
letters refer to sct gene names according to the unified
nomenclature suggested by Hueck in 1998 (Microbiol Mol Biol
Rev 62: 379–433). sycE and sycD: genes encoding for SycE-like
and SycD/LcrH-like T3SS chaperones. All SycD/LcrH predicted
T3SS chaperones contain conserved tetratricopeptide repeats
domains (TPRs).
Found at: doi:10.1371/journal.pone.0008423.s006 (6.98 MB TIF)
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